Search research articles
Contact Us
Filters
Showing results (141-150 of 170) with videos related to
Page
of 17
Sort By:
Annals of the New York Academy of Sciences
|
July 21, 1998
Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?
G R Hanson, J W Gibb, R R Metzger, et al.
Brain Research
|
September 29, 1987
Characterization of dopaminergic influence on striatal-nigral neurotensin systems
A A Letter, L A Matsuda, K M Merchant, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1985
Role of dopamine in the neurotoxic effects of methamphetamine
C J Schmidt, J K Ritter, P K Sonsalla, et al.
Brain Research
|
August 2, 1991
N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems
N A Singh, L P Midgley, L G Bush, et al.
Neuroscience
|
March 23, 2005
Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats
W R Crowley, G Ramoz, K A Keefe, et al.
European Journal of Pharmacology
|
October 20, 1992
Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine
I Elayan, J W Gibb, G R Hanson, et al.
The Review of Scientific Instruments
|
December 3, 2008
Scrape-off layer reflectometer for Alcator C-Mod
G R Hanson, J B Wilgen, C Lau, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1993
Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity
I Elayan, J W Gibb, G R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1992
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems
M Johnson, I Elayan, G R Hanson, et al.
Brain Research Bulletin
|
January 1, 1997
Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol
G R Hanson, L G Bush, V L Taylor, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 170) with videos related to
Sort By:
Page
of 17
Annals of the New York Academy of Sciences
|
July 21, 1998
Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?
G R Hanson, J W Gibb, R R Metzger, et al.
Brain Research
|
September 29, 1987
Characterization of dopaminergic influence on striatal-nigral neurotensin systems
A A Letter, L A Matsuda, K M Merchant, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1985
Role of dopamine in the neurotoxic effects of methamphetamine
C J Schmidt, J K Ritter, P K Sonsalla, et al.
Brain Research
|
August 2, 1991
N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems
N A Singh, L P Midgley, L G Bush, et al.
Neuroscience
|
March 23, 2005
Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats
W R Crowley, G Ramoz, K A Keefe, et al.
European Journal of Pharmacology
|
October 20, 1992
Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine
I Elayan, J W Gibb, G R Hanson, et al.
The Review of Scientific Instruments
|
December 3, 2008
Scrape-off layer reflectometer for Alcator C-Mod
G R Hanson, J B Wilgen, C Lau, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1993
Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity
I Elayan, J W Gibb, G R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1992
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems
M Johnson, I Elayan, G R Hanson, et al.
Brain Research Bulletin
|
January 1, 1997
Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol
G R Hanson, L G Bush, V L Taylor, et al.
Page
of 17